I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Supplementary Tables 1-5: Optimum immunotherapy method acco..:
Lecai Xiong (11760140)
;
Yi Cai (233861)
;
Xiao Zhou (122661)
...
https://figshare.com/articles/dataset/Supplementary_Tables_1-5_Optimum_immunotherapy_method_according_to_PD-L1_expression_in_advanced_lung_cancer_a_network_meta-analysis/17085986. , 2021
Link:
https://doi.org/10.25402/fon.17085986.v1
RT Journal T1
Supplementary Tables 1-5: Optimum immunotherapy method according to PD-L1 expression in advanced lung cancer: a network meta-analysis
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17085986&Exemplar=1&LAN=DE A1 Lecai Xiong (11760140) A1 Yi Cai (233861) A1 Xiao Zhou (122661) A1 Peng Dai (1327728) A1 Yanhong Wei (2445391) A1 Jinping Zhao (348634) A1 Hexiao Tang (5339195) YR 2021 K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Molecular Targets K1 Solid Tumours K1 advanced lung cancer K1 immune checkpoint inhibitor K1 immunotherapy K1 combination therapy K1 chemotherapy K1 PD-L1 expression K1 Overall survival K1 progression free survival K1 Subgroup analysis K1 network meta-analysis JF https://figshare.com/articles/dataset/Supplementary_Tables_1-5_Optimum_immunotherapy_method_according_to_PD-L1_expression_in_advanced_lung_cancer_a_network_meta-analysis/17085986 LK http://dx.doi.org/https://doi.org/10.25402/fon.17085986.v1 DO https://doi.org/10.25402/fon.17085986.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)